Global Patent Index - EP 4021411 A4

EP 4021411 A4 20230809 - LIQUID PHARMACEUTICAL COMPOSITIONS OF MELATONIN FOR ORAL AND PARENTERAL ADMINISTRATION

Title (en)

LIQUID PHARMACEUTICAL COMPOSITIONS OF MELATONIN FOR ORAL AND PARENTERAL ADMINISTRATION

Title (de)

FLÜSSIGE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON MELATONIN ZUR ORALEN UND PARENTERALEN VERABREICHUNG

Title (fr)

COMPOSITIONS PHARMACEUTIQUES LIQUIDES DE MÉLATONINE POUR ADMINISTRATION ORALE ET PARENTÉRALE

Publication

EP 4021411 A4 20230809 (EN)

Application

EP 20859314 A 20200831

Priority

  • IN 201921035140 A 20190830
  • IN 2020050759 W 20200831

Abstract (en)

[origin: WO2021038601A1] The present invention relates to a liquid compositions for the oral and parenteral administration of melatonin in the form of aqueous solutions comprising melatonin and at least one but preferably two ingredients for enhancing properties of the composition wherein the ingredient(s) belong to the group consisting of solubilizers, polymeric solubilizers, crystal inhibitors, stabilizers, anti-oxidants, chelating agent and complexing agent and combinations thereof and the properties enhanced are at least solubility and stability. Preferably the compositions are pharmaceutical compositions. Preferably, the compositions are nutraceutical compositions.

IPC 8 full level

A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/4045 (2006.01); A61K 47/10 (2017.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61P 1/00 (2006.01); A61P 9/00 (2006.01); A61P 29/00 (2006.01)

CPC (source: EP)

A61K 9/0019 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/2018 (2013.01); A61K 31/4045 (2013.01); A61K 47/10 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61P 1/00 (2018.01); A61P 9/00 (2018.01); A61P 29/00 (2018.01)

Citation (search report)

  • [XY] US 2017112810 A1 20170427 - ACUNA CASTROVIEJO DARIO [ES], et al
  • [Y] WO 9947175 A1 19990923 - RECORDATI CHEM PHARM [CH]
  • [X] WO 2018167162 A1 20180920 - CHIESI FARM SPA [IT]
  • [A] WO 2010062153 A1 20100603 - GARCIA PEREZ MIGUEL ANGEL [MX], et al
  • [X] US 9468626 B2 20161018 - RASCHINI ANNAMARIA SOLIANI [IT], et al
  • [XY] WO 2012156565 A1 20121122 - UNIV GRANADA [ES], et al
  • [Y] US 2018264013 A1 20180920 - DILL DAVID A [US]
  • [A] LI HAIYING ET AL: "A simple and effective method to improve bioavailability of glimepiride by utilizing hydrotropy technique", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 77, 1 September 2015 (2015-09-01), NL, pages 154 - 160, XP055794588, ISSN: 0928-0987, DOI: 10.1016/j.ejps.2015.06.016
  • [Y] JASPRICA I ET AL: "Determination of meglumine in pharmaceutical formulations using high performance liquid chromatography", PHARMAZIE, vol. 66, no. 12, 1 December 2011 (2011-12-01), DE, pages 916 - 919, XP093058870, ISSN: 0031-7144, Retrieved from the Internet <URL:https://www.ingentaconnect.com/content/govi/pharmaz/2011/00000066/00000012/art00002?crawler=true> DOI: 10.1691/ph.2011.1059
  • See also references of WO 2021038601A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2021038601 A1 20210304; AU 2020339867 A1 20220414; EP 4021411 A1 20220706; EP 4021411 A4 20230809

DOCDB simple family (application)

IN 2020050759 W 20200831; AU 2020339867 A 20200831; EP 20859314 A 20200831